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Abstract
Background Despite the widely reported success of total
joint arthroplasty (TJA) in reducing pain and improving
quality of life and function for patients with hip or knee
osteoarthritis, rates of TJA use vary widely throughout the
United States, with broad disparities based on geographic,
racial, and socioeconomic factors. Shared decision-making
approaches, which require an exchange of information
between patients and their physicians, can be helpful in
improving patient satisfaction with their treatment decision
and appropriate use of TJA.
Questions/hypotheses Expected-value decision analysis
models incorporating evidence-based outcome data with
individual patient preferences regarding health states and
willingness to pay, when used in shared decision-making
models, will improve satisfaction among patients with hip
or knee osteoarthritis and lead to more appropriate use
of TJA.
Proposed Program Patients with hip or knee osteoar-
thritis will be randomized to usual care or participation in a
shared decision-making intervention. Patients in the shared
decision-making intervention arm will have their prefer-
ences for individual health states related to osteoarthritis
and TJA measured using the time trade-off technique, and
these values will be incorporated in an expected-value
decision analysis model, which also will incorporate the
patient’s willingness to pay for a particular treatment
intervention and evidence-based outcome probabilities.
The patient’s decision for operative versus nonoperative
care and their level of satisfaction with their decision will
be compared using chi square and Mann-Whitney rank-
sum tests.
Signiﬁcance Information regarding patient preferences
for particular health states and willingness to pay can be
combined with evidence-based outcome data in expected-
value decision analysis models, which will help inform
shared clinical decision making between surgeons and their
patients with hip or knee osteoarthritis.
Questions/hypotheses
Expected-value decision analysis models incorporating
evidence-based outcome data with individual patient
preferences regarding health states and willingness to pay,
when used in shared decision-making models, will improve
satisfaction among patients with hip or knee osteoarthritis
and lead to more appropriate use of TJA.
Background
TJA decreases pain and improves function and quality of
life for patients with disabling osteoarthritis (OA) of the
hip and knee [19]. However, some investigators have
documented substantial geographic variation in TJA
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hard-on-hard bearings) that cannot be explained by dif-
ferences in population characteristics alone [4, 18, 22, 24].
Researchers from the Dartmouth Center for Evaluative
Clinical Sciences [13, 14, 23] have suggested one poten-
tially helpful tool to address geographic variation in
practice patterns would be an increased emphasis on
informing patients, eliciting their preferences, and involv-
ing them in the choice of treatment. Others have noted an
important prerequisite for successful shared decision-
making (SDM) is gathering and synthesizing evidence-
based outcome data with which to educate patients so that
their choices are as informed as possible [1, 2].
SDM, as opposed to more traditional authoritative and
paternalistic models of the patient-practitioner relationship,
requires information exchange between the clinician and
the patient, who then deliberate together and decide on the
optimal treatment option [11]. Researchers have recog-
nized the need to temper the role of so-called ‘‘medical
opinion’’ and enhance the role of patient preference in
medical decision making [9, 11, 17]. Some investigators
[6, 7] have noted that although some patients want com-
plete control over their healthcare decision making and
others want physicians to make all treatment decisions,
most would prefer to share the decision making with their
physicians. Hawker et al. [9] have shown professional
opinion concerning a patient’s need for TJA can differ
from the patient’s preferences.
Although physicians often have superior knowledge
regarding the pathophysiology of a patient’s disease and
the risks and beneﬁts of speciﬁc treatment options, they
lack information regarding individual patient preferences
important in formulating a treatment plan for a particular
patient. Expected-value decision analysis models can be
used to supplement more traditional shared decision-
making tools (eg, DVDs and booklets describing treatment
alternatives) by incorporating the best available evidence-
based outcome data with individual patient preferences, as
measured from direct preference assessment. The purpose
of an expected-value decision analysis model is to help
patients and clinicians choose between two or more treat-
ment alternatives, each of which can lead to several
possible outcomes, with chance determining the outcome
experienced by an individual patient (Fig. 1).
Health state utility, which is preference-based measure
of health status ranging from 1.0 (perfect health) to 0.0
(death), refers to the desirability or preference that indi-
viduals or societies have for a given health outcome [16].
Utility scores also can be used to weigh time spent in each
health state to estimate quality-adjusted life years (QALYs)
gained, which then can be used as the denominator in cost-
utility analyses and cost-effectiveness analyses. The three
most commonly used approaches for direct assessment of
utility are the time trade-off (TTO), standard-gamble, and
visual analog scale (also referred to as rating scale) tech-
niques [21]. The TTO technique (Fig. 2) derives values for
various health states by asking patients how many years in
their current state of health they would be willing to give
up to live a ﬁxed number of years in excellent health [8].
Another technique for direct preference assessment is the
standard-gamble technique (Fig. 3), which involves offer-
ing the patient two treatment alternatives. Alternative 1 is a
Fig. 1 A simple decision tree for THA versus nonoperative care is
shown. The square indicates a decision node representing a choice
between two or more treatments being considered (eg, THA and
nonoperative care). The circles are chance nodes, reﬂecting possible
mutually exclusive outcomes with the probability shown below each
branch. The triangles are terminal nodes for the ﬁnal outcomes and to
the right of each terminal node is the ‘‘reward,’’ which can be utility,
QALYs, cost, or any other quantitative measure of interest associated
with each outcome. The expected value of each choice is calculated
by multiplying the probability of each branch by its reward in a
weighted average in a process known as ‘‘folding back.’’ In the case
above, the expected value of THA is 9.6, which is favored over the
expected value of nonoperative care of 5.4.
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123treatment with two possible outcomes: either the patient
returns to normal health and lives for an additional ﬁnite
number of years (probability p) or the patient dies imme-
diately. Alternative 2 has the certain outcome of a chronic
state of illness or disability (i) for a ﬁnite period of time.
The probability (p) is varied until the subject is indifferent
between the two alternatives, at which point the value for
chronic state i is set equal to p [15]. Finally, the visual
analog scale (or rating scale) technique involves asking
patients to simply locate various health states on a linear
scale from 0 to 1 [15]. Although it has been suggested this
technique is the simplest to administer and easiest for
patients to understand, one drawback of the technique is
the tendency for most patients to rate their health as
‘‘average’’ versus the health of their peers and thus to
center-bias the utility assessments [20]. However, the
visual analog scale technique is valid and reproducible for
measuring utility in patients with OA and TJA [3].
In addition to considering individual patient preferences
for various health states and downstream consequences
associated with their care, decision aids should also
incorporate patient preferences and values regarding the
cost of care. As consumer-focused health plans that require
patients to assume a larger burden of healthcare costs have
increased in popularity in the United States, cost consid-
erations have become increasingly important for individual
patients when seeking the best value for their healthcare
dollars. Thus, SDM tools will need to incorporate not only
patient preferences regarding individual health states and
health outcomes but also information regarding their will-
ingness to pay for a particular treatment intervention or
desired health state.
Proposed Program
All patients who are referred for evaluation and treatment
of hip or knee OA will be asked to participate in a ran-
domized controlled trial (RCT). Patients who choose to
participate will be randomized to one of two groups (SDM
intervention [Group 1] and usual care [Group 2]). All
patients will receive standard patient education materials,
including literature regarding OA, TJA, and the opportu-
nity to participate in a patient education class regarding
TJA taught by a clinical nurse specialist (per our standard
treatment protocol for all patients). Patients in Group 1 will
also be offered the opportunity to participate in the SDM
program, and patients in Group 2 will not be offered this
option.IndividualpatientpreferencesforpatientsinGroup1
willbedeterminedbydirectpreferenceassessmentusingthe
TTO method as describedabove, andwillingness topay will
be measured using a validated questionnaire. With the help
of a trained research nurse, patients will be given the
opportunity to enter their preferences and willingness to pay
intoanexpected-valuedecisionanalysismodelthatalsowill
include evidence-based outcome probabilities for each
treatment option, and to discuss with their surgeon which
treatment option (surgical versus nonsurgical) would pro-
vide them with the greatest short- and long-term beneﬁts in
termsofQALYsgainedandcost/QALY,basedonthemodel
output and the sensitivity analysis.
The primary outcome measures will be the decision to
undergo operative (eg, TJA) or nonoperative treatment and
patient satisfaction with their decision measured using the
satisfaction with decision scale described previously and
validated for use in healthcare decision making by Holmes-
Rovner et al. [10]. To determine the effect of the SDM
Fig. 2 A graph illustrates the TTO technique for direct preference
assessment. This technique derives values for various health states by
asking patients how many years in their current state of health they
would be willing to give up to live a ﬁxed number of years in
excellent health (x) or the time living the rest of their lives in their
current state of health (t). i is the direct preference score for the health
state. Time, x, varies in values until the respondent is indifferent
between the two choices. The higher the value a person places on the
state i, the greater the time x would be required for the respondent to
be indifferent between the choices being presented [8].
Fig. 3 A ﬂowchart illustrates the standard-gamble technique for
direct preference assessment. This technique involves offering the
patient two treatment alternatives. In this example, Alternative 1 is a
treatment with two possible outcomes: either the patient returns to
normal health and lives for an additional ﬁnite number of years
(probability p) or the patient dies immediately (probability 1  p).
Alternative 2 has the certain outcome of a chronic state of illness or
disability (i) for a ﬁnite period of time. The probability (p) is varied
until the subject is indifferent between the two alternatives, at which
point the value for chronic state i is set equal to p [15].
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123intervention on choice of treatment, the treatment option
(operative versus nonoperative) chosen by patients in
Group 1 and Group 2 will be compared using the chi square
test. Satisfaction with decision values for each group will
be compared using the Mann-Whitney rank-sum test. Sta-
tistical signiﬁcance will be based on an a level of 0.05.
Limitations
Despite the novel concepts outlined in our proposed pro-
gram, there are several potential pitfalls and limitations that
we need to be prepared to address. First, patients may
prefer to have their surgeon make their treatment decision
for them and therefore may be reluctant to participate in the
RCT. The demographic, socioeconomic, and clinical
characteristics of patients who choose to participate in the
RCT versus those who decline will be tracked and com-
pared to look for biases that may affect the generalizability
of the results. Second, patients and surgeons may have
difﬁculty grasping the concept of incorporating their stated
preferences for particular health states and evidence from
the literature regarding treatment outcomes for hip and
knee OA into their medical decision making. Furthermore,
patients rarely pay out of pocket for their medical care and
therefore often are insensitive to the cost of care, which
may bias their responses to the willingness to pay ques-
tionnaire. However, even if this is the case, we will be able
to study the impact of the proposed intervention on treat-
ment choice (eg, operative versus nonoperative) and patient
satisfaction. Finally, as clinical decision making and
patient satisfaction are inﬂuenced by many factors, it may
be difﬁcult to assess the impact of the SDM intervention on
treatment choice and patient satisfaction. However, the
RCT study design will help mitigate some of the bias
associated with other independent factors affecting treat-
ment choice and patient satisfaction.
Next Steps
Although SDM tools have the potential to improve patient
satisfaction and lead to more appropriate use of scarce
healthcare resources, incorporating them into general
clinical practice, especially busy outpatient orthopaedic
practices, may prove to be challenging. Many physician
practices already are feeling pressured by increasing
overhead and ﬂat reimbursement, and adding a potentially
beneﬁcial but relatively unproven intervention that could
add time and expense without any clear ﬁnancial beneﬁt to
their practice may be met with resistance by clinicians and
ofﬁce managers. These challenges will need to be ad-
dressed in several ways before SDM approaches are widely
adopted in clinical practice. First, to investigate the feasi-
bility of implementing a SDM program into busy
orthopaedic surgical practices, we plan to measure and
compare total visit time and provider satisfaction for each
encounter for patients in Groups 1 and 2. It is possible
having patients review evidence-based information
regarding treatment alternatives before their ofﬁce visit
could improve the efﬁciency of the visit by allowing the
surgeon to focus on helping the patient reach a treatment
decision, rather than spending time answering questions
regarding what treatment options are available for hip or
knee OA. Second, some states and policymakers are con-
sidering expanding legislation that would provide funding
to study the use of SDM programs and in some cases
require such programs to be offered to patients as part of
the informed-consent process [12]. Finally, the recently
passed federal Patient Protection and Affordable Care Act
(PPACA) includes several demonstration projects that
would provide additional reimbursement to clinicians who
incorporate SDM approaches into their practice, which
could offset some of the costs associated with implemen-
tation and stimulate more physician practices to adopt
SDM tools into their clinical practices, especially if studies
like ours are able to show value in terms of improved
patient satisfaction and more efﬁcient use of resources.
Implications and Future Directions
An increase in consumer demand has led to a sharp rise in
the volume of publicly available information regarding
chronic disease processes such as OA and treatment
options such as TJA. At the same time, increased emphasis
on direct-to-consumer advertising in OA and TJA [5] have
led to concerns by clinicians and policy makers regarding
the source and accuracy of information patients use when
making important decisions regarding their healthcare.
With an increasing trend toward public reporting of
information regarding the cost and quality of healthcare,
patients are being asked to take on a larger role in their
healthcare decision making and to share a greater burden of
the costs associated with their care. As these trends evolve,
SDM tools will become increasingly important in helping
patients and clinicians reach decisions regarding the
treatment of chronic conditions such as OA.
Several health services researchers and policy makers
have suggested rates of use of TJA may be more dependent
on the supply of orthopaedic surgeons than the prevalence
of disease [4, 18, 22, 24]. Understanding how patient and
provider choices regarding the timing of TJA with respect
to the severity of pain, disability, and functional decline,
choice of implant, and type of procedure impact clinical
outcomes is important in helping inform true SDM
2084 Bozic and Chiu Clinical Orthopaedics and Related Research
1
123between patients and clinicians. Expected-value decision
analysis models incorporating evidence-based outcome
data with individual patient preferences regarding health
states and willingness to pay could be extremely valuable
for patients and clinicians when considering treatment
options for patients with hip or knee OA.
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